In summary, our findings indicate that repeated low-intensity FUS/MB led to evident improvement of memory impairments, concurrent with amelioraton of both Aβ and tau pathology, in a triple transgenic AD mouse model in an early-moderate stage of pathology. Here, MAPT is linked to Alzheimer disease.